検索ワード: hoechst (英語 - マルタ語)

industry park hoechst
kg industry park hoechst

hoechst/rhône-poulenc159
hoechst / rhône-poulenc159

hoechst marion roussel ltd.
hoechst marion roussel ltd.

hoechst ag, frankfurt/main, germany,
hoechst ag, frankfurt/main, il-Ġermanja,

kg industry park hoechst 65926 frankfurt am main germany
kg industry park hoechst 65926 frankfurt am main il- Ġermanja

insuman infusat has been developed for use in hoechst infusor and h-tron.
insuman infusat kien żviluppat għall-użu ma’ hoechst infusor u h-tron.

it is designed for use in the hoechst infusor and h-tron insulin pumps.
huwa magħmul għall-użu mal- pompi ta’ l-insulina, hoechst infusor u h-tron.

insuman infusat comes in cartridges designed for use in hoechst infusor and h-tron.
insuman infusat huwa fornut f’skartoċċi magħmulin għall-użu ma’ hoechst infusor u h-tron.

in sulin human winthrop infusat has been developed for use in hoechst infusor and h-tron.
insulin human winthrop infusat kien żviluppat għall- użu ma ’ hoechst infusor u h- tron.

insulin human winthrop infusat comes in cartridges designed for use in hoechst infusor and h-tron.
insulin human winthrop infusat huwa fornut f’skartoċċi magħmulin għall-użu ma’ hoechst infusor u h-tron.

hoechst in 1997, escaped the imposition of a ne because of its cooperation with the commission under the leniency notice.
mcaa tagħha minn hoechst fl-1997, ħarbet l-impożizzjoni ta’ multa minħabba li kkooperat mal-kummissjoni skond lavviż ta’ klemenza.

it comes in cartridges designed for use in hoechst infusor and h-tron (insulin pumps).
huwa fornut f’skartoċċi magħmulin għall-użu ma’ hoechst infusor u h-tron (pompi ta’ l-insulina).

italy received a similar application on 3 july 1996 from hoechst schering agrevo gmbh (now bayer crop science concerning ethoxysulfuron.
l-italja rrċeviet applikazzjoni simili fit-3 ta' lulju 1996 minn hoechst schering agrevo gmbh (issa bayer dwar ix-xjenza tal-ucuħ tar-raba rigward ethoxysulfuron.

aventis was itself the result of a merger between hoechst and rhône-poulenc which was cleared in august 1999, subject to conditions.
l-aventis kienet hija stess ir-riżultat ta’ amalgamazzjoni bejn hoechst u rhône-poulenc li ġiet approvata f’awissu 1999, bla ħsara għall-kundizzjonijiet.

a fourth undertaking, clariant, which had acquired its mcaa business from hoechst in 1997, escaped the imposition of a fine because of its cooperation with the commission under the leniency notice.
ir-raba’ intrapriża, clariant, li kienet akkwistat il-kummerċ ta’ l-mcaa tagħha minn hoechst fl-1997, ħarbet l-impożizzjoni ta’ multa minħabba li kooperat mal-kummissjoni skond l-avviż ta’ klemenza.

sanofi-aventis ramipril protect 2,5 mg tabletten deutschland gmbh ramipril protect 5 mg tabletten industriepark hoechst ramipril protect 10 mg tabletten d-65926 frankfurt am main ramipril protect startset germany
ramipril protect 2, 5 mg tabletten ramipril protect 5 mg tabletten ramipril protect 10 mg tabletten ramipril protect startset

sanofi-aventis delix 2,5 mg tabletten deutschland gmbh delix 5 mg tabletten industriepark hoechst delix protect 10 mg tabletten d-65926 frankfurt am main delix hope 10 mg tabletten germany delix hope startset delix protect startset
delix 2, 5 mg tabletten delix 5 mg tabletten delix protect 10 mg tabletten delix hope 10 mg tabletten delix hope startset delix protect startset

although the commission had clearly displayed its intention not to disclose to the cooperating undertakings, in particular to hoechst, the fact that other undertakings had taken steps to obtain immunity from a fine, at the same it assured another undertaking that ‘fair warning’would begiven to it if another company looked like overtaking it in relation to cooperation.
bl-istess mod, ilqorti talprim’istanza rrilevat li, għalkemm jirriżulta wkoll minn din issentenza li l-fatt lirrikorrenti tkun l-unika importatriċi awtorizzata tal-prodotti kkonċernat huwa fattur rilevanti, dan mhuwiex biżżejjed, fih innifsu, sabiex juri l-interess individwali tagħha.